Search

everythinglearnresearchcommunity

for

Search:↓

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

CD34 is crucial for skin tumor development in mice.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Skin cancer often starts from Lgr5+ progenitor cells.

Cats likely have a reactive skin condition, while dogs may have a more complex, possibly cancerous one.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Reduced CD44 expression may cause abnormal hyaluronate buildup in cutaneous myxoma.

A rare type of skin lymphoma was identified, affecting hair follicles and sweat glands.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

Alopecia areata involves unique activation of certain immune cells.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Clonally expanded CD8+ T cells cause alopecia areata.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Hodgkin's lymphoma can show up as hair loss.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

HPV16-transformed cells can change human skin cell properties, aiding tumor growth.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

Changing CDK4 levels affects the number of stem cells in mouse hair follicles.